An AI system can produce a polished molecular-research report without producing a useful experimental result. The report might contain a genuine tool call, a real output file and a ranking that still answers the wrong scientific question. Evaluating an AI scientist therefore requires following the evidence between steps.
NVIDIA’s BioNeMo Agent Toolkit makes that issue concrete. It connects agents to scientific capabilities. The practical question is how a reader can distinguish a coordinated computational workflow from a claim that a medicine has been discovered.
Identify what the toolkit contributes
In its June 23, 2026 technical explanation, NVIDIA describes callable tools for tasks including structure prediction, molecular generation and docking. NIM supplies model services; BioNeMo Skills describe their purpose, inputs, parameters, output artifacts and failure modes. The agent chooses and uses tools within that interface.
This is the manufacturer’s account of its platform. It supports an explanation of the architecture, not an independent finding that the system improves clinical outcomes. The article below proposes a way to inspect a hypothetical workflow; it does not report an experiment performed with BioNeMo.
The division of work matters. A language-model explanation, a computational prediction and a laboratory measurement should retain their own labels. Passing information between them should not erase how that information was produced.
Give the hypothetical workflow a narrow question
Imagine a research team comparing three fictional candidate molecules, A, B and C, against a protein target. The team’s question is deliberately small: which candidate deserves the next experimental check? It is not asking which molecule should become a treatment.
Before running a tool, write down the target, the input structure being used, what is already known and the comparison criterion. Add an unresolved-assumptions box. If a conclusion depends on the relevance of that target to a disease, the workflow should identify the supporting evidence rather than letting a plausible name stand in for it.
This question sheet gives later outputs a reference point. Without it, a successful computation can gradually become an answer to a broader question nobody tested. “Candidate A ranked first under these settings” and “candidate A will help patients” have very different evidentiary burdens.
Require a record at every handoff
For each step, ask for the input identifier, the tool and model version, the settings, the returned artifact and any error or warning. A summary alone is too easy to detach from the computation it describes.
A fictional run record might say that a specified structure file and candidate file were submitted to a docking tool, followed by a returned pose file and a score. That record makes the claim inspectable. It does not by itself tell the reviewer that the biological setup was appropriate.
Keep failed calls in the record, with a different status from poor predictions. If candidate B’s input could not be parsed, label B not evaluated, state the parsing failure, and leave it outside the biological ranking. Putting it last would convert a software failure into a scientific result. A ranking of A and C can be valid for those two inputs while the three-candidate comparison remains incomplete.
The same care applies to missing artifacts. A sentence saying “docking completed” should not silently replace the file the reviewer needs. Ask for the artifact or mark the step unverified. This is a proposed review practice, not a claim that every toolkit deployment automatically enforces it.
Read a ranking as a conditional result
Suppose the report ranks A above C and leaves B unresolved. The next sentence should state what criterion produced that order and which assumptions were held fixed. Do not invent a probability of success from a score whose meaning has not been established.
A useful challenge is to ask what could change the ranking. Would a different justified input preparation or model choice matter? Has the team checked whether the apparent winner benefits from an input mistake? Those questions identify work to do; they do not establish the size of any particular model’s error.
NVIDIA’s troubleshooting guidance itself advises checking biological setup before trusting implausible docking or binding results and applying downstream scientific criteria to promising designs. A neatly formatted table should therefore begin the review conversation rather than close it.
Keep development evidence separate
The FDA’s description of discovery and development explains that promising compounds require experiments on matters including absorption, metabolism, excretion, dosage, toxicity and interactions. A computational ranking has not supplied all those observations simply because it appears in a drug-discovery workflow.
For the fictional candidates, a responsible next-step note would name the remaining question and the evidence needed to answer it. “Compare these candidates in a suitable experiment” is a proposed action. “Candidate A is safe” would require evidence that this example has not provided.
This separation also makes a failed follow-up informative. If the original record preserves the input, model output and rationale, the team can examine where its expectation broke down. If the report preserves only a triumphant conclusion, there is much less to learn from the failure.
Evaluate the loop before celebrating the label
A reader assessing a demonstration can request the exact question, the chain of artifacts, and the unresolved scientific checks. The agent task-verification exercise shows how to define the software finish condition. For a scientific workflow, add the separate question of what the returned artifact can establish biologically.
For example, a demo may convincingly show that an agent selected a tool and returned the expected file type. That is a software-workflow accomplishment. It should be credited at that level, without turning it into a success rate for discovering medicines.
An effective coordinator can make complex work easier to inspect and repeat. Its value still depends on the validity of the scientific steps it coordinates. With BioNeMo, the interesting development is the interface between an agent and a scientific toolbox. The strongest report leaves the next researcher able to see what happened, what remains uncertain and why a particular experiment is being proposed.
